Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer.

5-fluorouracil FCU1 TG6002 dog mammary tumor oncolytic virotherapy suicide gene therapy translational research vaccinia virus

Journal

Molecular therapy oncolytics
ISSN: 2372-7705
Titre abrégé: Mol Ther Oncolytics
Pays: United States
ID NLM: 101666776

Informations de publication

Date de publication:
16 Dec 2020
Historique:
received: 02 03 2020
accepted: 29 08 2020
entrez: 19 10 2020
pubmed: 20 10 2020
medline: 20 10 2020
Statut: epublish

Résumé

Oncolytic virotherapy is a promising therapeutic approach for the treatment of cancer. TG6002 is a recombinant oncolytic vaccinia virus deleted in the thymidine kinase and ribonucleotide reductase genes and armed with the suicide gene

Identifiants

pubmed: 33072863
doi: 10.1016/j.omto.2020.08.020
pii: S2372-7705(20)30137-6
pmc: PMC7533293
doi:

Types de publication

Journal Article

Langues

eng

Pagination

57-66

Informations de copyright

© 2020 The Author(s).

Références

J Vet Diagn Invest. 2014 Apr 23;26(3):390-403
pubmed: 24760135
Vet J. 2018 Oct;240:6-13
pubmed: 30268334
Nat Rev Microbiol. 2005 Mar;3(3):201-13
pubmed: 15738948
Vet Pathol. 2011 Jan;48(1):132-46
pubmed: 21147766
Front Oncol. 2017 May 23;7:96
pubmed: 28589082
Clujul Med. 2016;89(1):38-49
pubmed: 27004024
BMC Genomics. 2009 Mar 27;10:135
pubmed: 19327144
Cancer Gene Ther. 2004 May;11(5):333-45
pubmed: 15107812
Cancer Gene Ther. 2015 Jan;22(1):30-43
pubmed: 25501992
Nature. 2010 Feb 18;463(7283):858
pubmed: 20164888
Biomaterials. 2010 Nov;31(32):8494-506
pubmed: 20709389
Vet Comp Oncol. 2016 Dec;14(4):395-408
pubmed: 25302859
Cancer Res. 2017 Aug 1;77(15):4146-4157
pubmed: 28536278
J Clin Oncol. 2015 Sep 1;33(25):2780-8
pubmed: 26014293
J Small Anim Pract. 2012 Jun;53(6):314-22
pubmed: 22647210
J Neurosurg. 2004 Jun;100(6):1049-59
pubmed: 15200120
Mol Ther Oncolytics. 2019 Mar 27;14:1-14
pubmed: 31011628
Am J Vet Res. 1995 Sep;56(9):1188-94
pubmed: 7486397
Reprod Domest Anim. 2011 Dec;46(6):1112-31
pubmed: 21645126
Mol Ther. 2006 Sep;14(3):361-70
pubmed: 16905462
Cancer Gene Ther. 2008 Jan;15(1):18-28
pubmed: 17992203
J Reprod Fertil Suppl. 2001;57:439-43
pubmed: 11787188
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1495-506
pubmed: 26359465
J Immunother Cancer. 2019 Jan 9;7(1):6
pubmed: 30626434
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Nature. 2011 Aug 31;477(7362):99-102
pubmed: 21886163
Mol Ther. 2005 Feb;11(2):180-95
pubmed: 15668130
Gene Ther. 2008 Oct;15(20):1361-71
pubmed: 18480846
Am J Vet Res. 1996 May;57(5):693-6
pubmed: 8723884
Oncoimmunology. 2015 Dec 8;5(2):e1117740
pubmed: 27057469
BMB Rep. 2009 Jun 30;42(6):315-23
pubmed: 19558788
Nat Rev Microbiol. 2014 Jan;12(1):23-34
pubmed: 24292552
J Vet Intern Med. 2008 Jul-Aug;22(4):976-84
pubmed: 18564221
J Mammary Gland Biol Neoplasia. 2002 Jan;7(1):3-15
pubmed: 12160084
Cancer Invest. 2000;18(8):781-92
pubmed: 11107448
J Natl Cancer Inst. 1969 Dec;43(6):1249-61
pubmed: 4319248
In Vitro Cell Dev Biol Anim. 2010 Feb;46(2):114-22
pubmed: 19915935
Front Oncol. 2020 Apr 28;10:617
pubmed: 32411603
Oncolytic Virother. 2018 Sep 05;7:79-93
pubmed: 30234074
J Surg Res. 2010 Oct;163(2):270-5
pubmed: 20691986
BMC Biol. 2012 Mar 22;10:29
pubmed: 22439642
Cell. 2015 Sep 24;163(1):39-53
pubmed: 26406370
Cancer Cell Int. 2010 Aug 13;10:26
pubmed: 20707917
J Vis Exp. 2017 Feb 13;(120):
pubmed: 28287576
J Immunol Methods. 2018 Apr;455:71-79
pubmed: 29408707
Vet Pathol. 2013 Jan;50(1):94-105
pubmed: 22688585
Breast Cancer Res. 2005;7(6):R1141-52
pubmed: 16457694
Oncoimmunology. 2015 Oct 6;5(2):e1080414
pubmed: 27057460
J Exp Clin Cancer Res. 2006 Mar;25(1):97-105
pubmed: 16761625
Transl Res. 2012 Mar;159(3):165-72
pubmed: 22340765
Nature. 2012 Mar 28;483(7391):544-5
pubmed: 22460893
Oncol Lett. 2018 Jun;15(6):8195-8205
pubmed: 29928319
Br J Cancer. 1982 Oct;46(4):675-81
pubmed: 7138772
Cancer Res. 2000 Jul 15;60(14):3813-22
pubmed: 10919655
Am J Vet Res. 1980 Jun;41(6):855-60
pubmed: 6254399
EMBO Mol Med. 2017 May;9(5):638-654
pubmed: 28289079
Res Vet Sci. 2006 Oct;81(2):218-24
pubmed: 16740286

Auteurs

Jérémy Béguin (J)

UMR Virologie, INRA, Ecole Nationale Vétérinaire d'Alfort, ANSES, Université Paris-Est, Maisons-Alfort 94700, France.
Transgene S.A., 400 Boulevard Gonthier d'Andernach, Parc d'innovation, CS80166, Illkirch-Graffenstaden Cedex 67405, France.
Service de Médecine Interne, Ecole Nationale Vétérinaire d'Alfort, Université Paris-Est, Maisons-Alfort, 94700, France.

Johann Foloppe (J)

Transgene S.A., 400 Boulevard Gonthier d'Andernach, Parc d'innovation, CS80166, Illkirch-Graffenstaden Cedex 67405, France.

Christelle Maurey (C)

Service de Médecine Interne, Ecole Nationale Vétérinaire d'Alfort, Université Paris-Est, Maisons-Alfort, 94700, France.

Eve Laloy (E)

UMR Virologie, INRA, Ecole Nationale Vétérinaire d'Alfort, ANSES, Université Paris-Est, Maisons-Alfort 94700, France.
Laboratoire d'Anatomo-cytopathologie, Biopôle Alfort, Ecole Nationale Vétérinaire d'Alfort, Université Paris-Est, Maisons-Alfort 94700, France.

Julie Hortelano (J)

Transgene S.A., 400 Boulevard Gonthier d'Andernach, Parc d'innovation, CS80166, Illkirch-Graffenstaden Cedex 67405, France.

Virginie Nourtier (V)

Transgene S.A., 400 Boulevard Gonthier d'Andernach, Parc d'innovation, CS80166, Illkirch-Graffenstaden Cedex 67405, France.

Christelle Pichon (C)

Transgene S.A., 400 Boulevard Gonthier d'Andernach, Parc d'innovation, CS80166, Illkirch-Graffenstaden Cedex 67405, France.

Sandrine Cochin (S)

Transgene S.A., 400 Boulevard Gonthier d'Andernach, Parc d'innovation, CS80166, Illkirch-Graffenstaden Cedex 67405, France.

Pascale Cordier (P)

Transgene S.A., 400 Boulevard Gonthier d'Andernach, Parc d'innovation, CS80166, Illkirch-Graffenstaden Cedex 67405, France.

Hélène Huet (H)

UMR Virologie, INRA, Ecole Nationale Vétérinaire d'Alfort, ANSES, Université Paris-Est, Maisons-Alfort 94700, France.
Laboratoire d'Anatomo-cytopathologie, Biopôle Alfort, Ecole Nationale Vétérinaire d'Alfort, Université Paris-Est, Maisons-Alfort 94700, France.

Eric Quemeneur (E)

Transgene S.A., 400 Boulevard Gonthier d'Andernach, Parc d'innovation, CS80166, Illkirch-Graffenstaden Cedex 67405, France.

Bernard Klonjkowski (B)

UMR Virologie, INRA, Ecole Nationale Vétérinaire d'Alfort, ANSES, Université Paris-Est, Maisons-Alfort 94700, France.

Philippe Erbs (P)

Transgene S.A., 400 Boulevard Gonthier d'Andernach, Parc d'innovation, CS80166, Illkirch-Graffenstaden Cedex 67405, France.

Classifications MeSH